Pliant Therapeutics Inc (NASDAQ:PLRX) price on Wednesday, July 02, rose 2.56% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $1.2.
A look at the stock’s price movement, the close in the last trading session was $1.17, moving within a range at $1.165 and $1.2499. The beta value (5-Year monthly) was 1.356. Turning to its 52-week performance, $16.10 and $1.10 were the 52-week high and 52-week low respectively. Overall, PLRX moved -16.67% over the past month.
Pliant Therapeutics Inc’s market cap currently stands at around $73.66 million, with investors looking forward to this quarter’s earnings report slated for on 2025-May-08.
Turning to the stock’s technical picture we see that short term indicators suggest on average that PLRX is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
5 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 5 recommend PLRX as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
PLRX’s current price about -13.11% and -15.36% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 37.93, while 7-day volatility ratio is 10.18% and 8.69% in the 30-day chart. Further, Pliant Therapeutics Inc (PLRX) has a beta value of 1.41. Analysts have given the company’s stock an average 52-week price target of $2.5, forecast between a low of $2 and high of $3. Looking at the price targets, the low is -66.67% off current price level while to achieve the yearly target high, price needs to move -150.0%. Nonetheless, investors will most likely welcome a -108.33% jump to $2.5 which is the analysts’ median price.
If we refocus on Pliant Therapeutics Inc (NASDAQ:PLRX), historical trading data shows that trading volumes averaged 2.22 over the past 10 days and 1.15 million over the past 3 months. The company’s latest data on shares outstanding shows there are 61.39 million shares.
The 11.97% of Pliant Therapeutics Inc’s shares are in the hands of company insiders while institutional holders own 86.94% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 3.36 million on 2025-06-13, giving us a short ratio of 3.14. The data shows that as of 2025-06-13 short interest in Pliant Therapeutics Inc (PLRX) stood at 561.99998 of shares outstanding, with shares short falling to 5.04 million registered in 2025-05-15. Current price change has pushed the stock -88.84% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the PLRX stock continues to rise going into the next quarter.
